Genasense Phase III Melanoma Trial Gets Green Light
This article was originally published in The Pink Sheet Daily
Executive Summary
Genta aims for first approval in tough disease, CEO tells “The Pink Sheet” DAILY.
You may also be interested in...
Genta Gets New FDA Action Date For Genasense In CLL
Firm has SPA for additional trial pending at agency, chairman said in an interview.
Genta Gets New FDA Action Date For Genasense In CLL
Firm has SPA for additional trial pending at agency, chairman said in an interview.
Genta Poised To Restart Tesetaxel Studies
FDA lifts clinical hold on Phase II oral taxane now headed back to the clinic in the second half.